Immune reconstitution and early infectious complications following nonmyeloablative hematopoietic stem cell transplantation

Hematology

Volumn 8, Issue 5, 2003, Pages 303-311

  Busca, Alessandro ^a   Lovisone, Elisabetta ^a   Aliberti, Sabrina ^a   Locatelli, Franco ^a   Serra, Anna ^b   Scaravaglio, Patrizia ^b   Omedé, Paola ^c   Rossi, Giuseppe ^c   Cirillo, Daniela ^a   Barbui, Anna ^a   Ghisetti, Valeria ^a   Dall'Omo, Anna Maria ^a   Falda, Michele ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b SAN LUIGI GONZAGA HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

CMV reactivation; Hematopoietic stem cell transplantation; Immune reconstitution; Infectious complications

Indexed keywords

ACICLOVIR; BUSULFAN; CD19 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; FOSCARNET; GANCICLOVIR; IDARUBICIN; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID; SULFAMETHOXAZOLE; THIOTEPA; TRIMETHOPRIM;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BACTEREMIA; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; MEMBRANE RECONSTITUTION; MORTALITY; MYCOSIS; NATURAL KILLER CELL; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 10744226870     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330310001612125     Document Type: Article

References (31)

1. Brown, R.A., Adkins, D., Khoury, H., Vij, R., Goodnough, L.T., Shenoy, S. and Di Persio, J.F. (1999) "Long term follow up of high risk allogeneic peripheral blood stem cell transplant recipients: graft versus host disease and transplant related mortality", J. Clin. Oncol. 17, 806-812.
2. Slavin, S., Nagler, A., Naparstek, E., et al. (1998) "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases", Blood 91, 756-763.
3. Khouri, I.F., Keating, M., Korbling, M., et al. (1998) "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies", J. Clin. Oncol. 16, 2817-2824.
4. Mohty, M., Faucher, C., Vey, N., et al. (2000) "High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation", Bone Marrow Transplant 26, 251-255.
5. Martino, R., Caballero, M.D., Canals, C., et al. (2001) "Reduced-intensity conditioning reudces the risk of severe infections after allogeneic peripheral blood stem cell transplantation", Bone Marrow Transplant 28, 341-347.
6. Maraninchi, D., Gluckman, E., Blaise, D., et al. (1987) "Impact of T-cell depletion on outcome of allogeneic bone marrow tranplantation for standard-risk leukaemias", Lancet 2, 175-178.
7. Curtis, R.E., Rowlings, P.A., Deeg, H.J., et al. (1997) "Solid cancers after bone marrow transplantation", N. Engl. J. Med. 336, 897-904.
8. Dupont, B. and Yang, S.Y (1994) "Histocompatibility", In: Forman, S.J., Blume, K.G. and Thomas, E.D., eds, Bone Marrow Transplant (Blaskwell Scientific Publications, Boston, MA), pp 22-40.
9. Small, T.N., Keever, C.A., Weiner-Feddus, S., et al. (1990) "B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny", Blood 76, 1647-1656.
10. Stelzer, G.T., Marti, G., Hurley, A., et al. (1997) "U:S:Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures", Cytometry 30, 214-230.
11. Maury, S., Mary, J.Y., Rabian, C., et al. (2001) "Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients", Br. J. Haematol. 115, 630-641.
12. Glucksberg, H., Storb, R., Fefer, A., et al. (1974) "Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors", Transplantation 18, 295-304.
13. Shulman, H.M., Sullivan, K.M., Weiden, P.L., et al. (1980) "Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients", Am. J. Med. 69, 204-211.
14. Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", J. Am. Stat. Soc. 53, 457-481.
15. Friedman, T.M., Varadi, G., Hopely, D.D., et al. (2001) "Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches", Biol. Blood Marrow Transplant 7, 656-664.
16. Nakai, K., Kanda, Y., Mineishi, S., et al. (2002) "Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin", Bone Marrow Transplant 29, 237-241.
17. Savage, W.J., Bleesing, J.J.H., Douek, D., et al. (2001) "Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism", Bone Marrow Transplant 28, 463-471.
18. Chao, N.F., Liu, C.X., Rooney, B., et al. (2002) "Nonmyeloablative regimen preserves Niches allowing for peripheral expansion of donor T-cell", Biol. Blood Marrow Transplant 8, 249-256.
19. De Gast, G.C., Verdonck, L.F., Middeldorp, J.M., et al. (1985) "Recovery of T-cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cell in the graft", Blood 66, 428-431.
20. Mackall, C.L., Granger, L., Sheard, M.A., et al. (1993) "T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny", Blood 82, 2585-2594.
21. Roux, E., Dumont-Girard, F., Starobinski, M., et al. (2000) "Recovery of immune reactivity after T cell depleted bone marrow transplantation depends on thymic activity", Blood 96, 2299-2303.
22. Ottinger, H.D., Beelen, D.W., Scheulen, B., Schaefer, U.W. and Grosse-Wilde, H. (1996) "Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow", Blood 88, 2775-2779.
23. Mossad, S.B., Avery, R.K., Longworth, D.L., et al. (2001) "Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation", Bone Marrow Transplant 28, 491-495.
24. Chakrabarti, S., Mackinnon, S., Chopra, R., et al. (2002) "High incidence of Cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution", Blood 99, 4357-4363.
25. Perez-Simon, J.A., Kottaridis, P.D. and Martino, R. (2002) "Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders", Blood 100, 3121-3127.
26. Bornhauser, M., Thiede, C., Schuler, U., et al. (2000) "Dose-reduced conditioning for allogenic blood stem cell transplantation: durable engraftment without antithymocyte globulin", Bone Marrow Transplant 26, 119-125.
27. Graber, C., De Almeida, K.N.F., Childs, R., et al. (2001) "CMV reactivation in nonmyeloablative HSCT", Bone Marrow Transplant 27, 775.
28. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., et al. (2001) "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects", Blood 97, 3390-3400.
29. Sarmiento, J.M., Dockrell, D.H., Schwab, T.R., Munn, S.R. and Paya, C.V (2000) "Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients", Clin. Transplant 14, 136-138.
30. Junghanss, C., Marr, K.A., Carter, R.A., et al. (2002) "Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study", Biol. Blood Marrow Transplant 8, 512-520.
31. Hagen, E.A., Stern, H., Porter, D., Duffy, K., Foley, K., Luger, S., Schuster, S.J., et al. (2003) "High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation", Clin. Infect. Dis. 36, 9-15.